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Abstract
Objective: To evaluate surgical treatment of chronic atrial 
fibrillation with ultrasound in patients with mitral valve disease, 
considering preoperative clinical characteristics of patients 
undergoing surgical procedure  and follow-up in the immediate 
postoperative period, in hospital and up to 60 months after 
discharge. 
Methods: We studied 100 patients with chronic atrial fibrillation 
and mitral valve disease who underwent surgical treatment using 
ultrasound ablation. Patient data were reviewed by consulting the 
control reports, including signs and symptoms, underlying disease, 
functional class, hospital stay, surgical procedure time, ablation 
time, immediate complications, and complications at discharged 
and up to 60 months later. Actuarial curve (Kaplan-Meier) was 
used for the study of permanence without recurrence after 12, 24, 
36, 48 and 60 months. 
Results: 86% of the patients had rheumatic mitral valve 
disease, 14% had degeneration of the mitral valve, 40% had mitral 
regurgitation, and 36% had mitral stenosis. Main symptoms 
included palpitations related to tachycardia by chronic atrial 
fibrillation (70%), congestive heart failure (70%), and previous 
episodes of acute pulmonary edema (27%). Early results showed 
that 94% of the patients undergoing ultrasound ablation reversed 
the rate of chronic atrial fibrillation, 86% being in sinus rhythm and 
8% in atrioventricular block. At hospital discharge, maintenance 
of sinus rhythm was observed in 86% of patients and there 
was recurrence of chronic atrial fibrillation in 8% of patients. At 
follow-up after 60 months, 83.8% of patients maintained the sinus 
rhythm. 
Conclusion: Surgical treatment of chronic atrial fibrillation with 
ultrasound concomitant with mitral valve surgery is feasible and 
satisfactory, with maintenance of sinus rhythm in most patients 
(83.8%) after 60 months of follow-up.
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INTRODUCTION
Atrial fibrillation (AF) is the most common and the most 
complex supraventricular arrhythmia, characterized by loss of 
atrial contraction, and its diagnosis is easily accomplished by 
clinical manifestation, cardiac auscultation, and electrocardiogram. 
The prevalence of AF is estimated at 0.4% in the general 
population and it increases proportionately with age, occurring 
in less than 1% of those below 60 years old and more than 6% 
in patients over 80 years old[1]. Regarding gender, its incidence 
is higher in men[2]. The occurrence of AF may be associated 
with other cardiopulmonary diseases, such as valvular disease, 
especially with the involvement of the mitral valve[3]. AF is termed 
chronic when it persists for more than a year or continues after 
the first episode.
The non-pharmacological treatment of AF includes 
techniques such as intraoperative cryoablation of the His bundle 
and the atrioventricular junction[4]; electrical cardioversion, with 
a high recurrence rate; left atrial isolation[5]; catheter ablation 
of the His bundle and permanent pacemaker implantation; 
catheter ablation of the atrioventricular junction and permanent 
pacemaker implantation; and “Corridor operation”.
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Electrophysiological mapping studies with computerized 
electrode system were performed by Cox et al.[6], who developed 
the surgical technique known as maze procedure. It consists of 
making incisions and sutures on the atrial wall, allowing the 
spread of electrical stimulation in the atria within a maze, and 
setting atrial rate.
The applicability of surgical techniques is inversely 
proportional to their complexity. In order to reduce the 
complexity of the “Cox operation”[7], several technical changes 
were introduced, such as modifications in the locations of atrial 
incisions; reduction of section lines and sutures on the atrial wall, 
known as “Mini Cox”[8]; and a unilateral procedure, only in the left 
atrium, called “Cox at Left”.
In Brazil, Jatene et al.[9] evaluated the results of late evolution 
of the Cox maze procedure for chronic atrial fibrillation (CAF) 
in patients with mitral valve disease. In addition, it has been 
demonstrated that, in patients with CAF and valvular disease, 
a combination of valve repair and completion of the Maze 
technique devised by Cox allows for the return to sinus 
rhythm[10]. Although of proven efficiency, the “maze technique”, 
as it is generally performed, uses dissection and opening of the 
atrial wall, followed by suture, which increases cardiopulmonary 
bypass (CPB) time and the chance of complications in the 
postoperative period.
The use of catheter ablation for the treatment of supraventricular 
arrhythmias stimulated the use of energy sources to cause linear 
ablative lesions, with either endocardial or epicardial application or 
both, replacing the section and suture of the atrial wall[11,12]. New 
energy sources capable of causing permanent blockage lines have 
been used[13] such as radiofrequency[14-18], microwave[19] (90=17), 
and ultrasound (US)[20,21].
This author, considering the experience with an US scalpel 
in the surgical treatment of refractory ventricular tachycardia[22], 
devised a new approach, applying US and using the scalpel 
(UltraCision®) to form injury lines that would determine the 
partitioning of the left and right atria, with less surgical and CPB 
time and consequent reduction in postoperative complications.
Several aspects justified this research, namely: difficulties in 
establishing drug treatment or other drugs indicated to eliminate 
CAF; complications caused by CAF, especially thromboembolism 
with increasing morbidity and mortality; presence of previous heart 
disease, most often injury of the mitral valve; advances in the study 
of the electrophysiological mechanisms of arrhythmia; description 
of the focal origin mechanism of AF in the pulmonary veins, as 
well as foci located in the vena cava; and demonstration that the 
ablations performed with US systems, through both endocardial 
and epicardial, are likely to cause transmural lesion. Thus, the aim 
of this study was to evaluate the surgical treatment of CAF with 
US in patients with mitral valve disease, considering preoperative 
clinical characteristics of patients undergoing surgical treatment 
for CAF and follow-up in the immediate postoperative period, at 
hospital discharge, and late postoperative of up to 60 months.
METHODS
We retrospectively and consecutively studied 100 patients 
with CAF and mitral valve disease with indication for surgical 
treatment, regardless of race, from various regions of the country, 
aged between 18 and 70 years (43.56±4.94 years), and with 63 
(63%) being female and 37 (37%), male. The patients underwent 
surgery by the author in the period between 1999 and 2004 and 
were surgically treated by ablation with US. All patients were 
treated at Hospital das Forças Armadas and Brasília Hospital, 
located in Brasilia/DF, Brazil.
Exclusion criteria were: pregnant women; children under 
16 years old; AF patients who were not considered chronic, 
with or without valvular heart disease; people with coronary, 
congenital and vascular diseases; transplant or indication for 
heart transplantation; patients undergoing two reoperations 
of the mitral valve; and those with other isolated or associated 
valve diseases (except the tricuspid valve disease). This study 
was approved by the Research Ethics Committee of São José 
do Rio Preto Medical School (FAMERP) (Protocol No. CAAE 
37374414.9.0000.5415).
Patient data were reviewed prospectively by consulting control 
records, including demographic variables (gender and age). Cardiac 
variables included clinical presentation (signs and symptoms), 
underlying disease, functional class, length of hospital stay (days), 
surgical procedure time (minutes), ablation time (minutes), 
intraoperative and postoperative complications (immediate, at 
hospital discharge and late postoperative, up to 60 months).
All patients had indication for mitral valve repair or 
replacement, in some cases for tricuspid valve repair and 
correction of CAF. US was used to perform the intraoperative 
ablation lines, in accordance with Brick et al.[23], using harmonic 
scalpel UltraCision®, trademark of Ethicon Endo Surgery, Division 
of Johnson & Johnson Professional Products (São Paulo, SP, Brazil).
After anoxic arrest, longitudinal left atriotomy was performed 
by clamping of the aorta. The ablation lines were carried out in 
inverted U-shape, surrounding the four pulmonary veins, by 
starting and finishing at the fibrous annulus of the heart toward 
the mitral valve. In patients with thrombi in the atrium and left 
atrium, thrombectomy was performed before ablation. Upon 
completion of the ablation lines, routine procedures were done 
for treatment of mitral disease with replacement or repair.
In the right atrium, after longitudinal opening with a beating 
heart, linear ablations were performed in the interatrial septum: 
1- from around the superior vena cava to around the inferior 
vena cava; 2- from the inferior vena cava to the bottom edge of 
the tricuspid valve annulus, passing close to the coronary sinus 
ostium, and 3- from the superior vena cava to the upper portion 
of the tricuspid annulus, taking care of the atrioventricular node.
A daily dose of 200 mg of amiodarone was maintained for six 
months for atrial remodeling and stabilization.
Data were analyzed using descriptive statistics (mean, 
standard deviation, median, minimum and maximum). The 
actuarial curve (Kaplan-Meier) for the study of permanence 
without recurrence after 12, 24, 36, 48 and 60 months in patients 
with CAF with confidence interval of 95% was used. The actuarial 
curve (Kaplan-Meier) was performed using the statistical 
program Statistical Calculations for Windows v.1.8.
RESULTS
Of the patients studied, 86% had rheumatic mitral valve 
disease and 14% presented degeneration of the mitral valve. The 
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analysis of valvular disease showed that 40% of the patients had 
mitral regurgitation, 36% had mitral stenosis, 19% had double 
mitral lesion, and 5% had mitral restenosis (Figure 1). In addition 
to mitral valve disease, 11% of the patients had associated 
tricuspid valve regurgitation, which was also corrected with 
valvuloplasty during the procedure.
Main symptoms included palpitations related to tachycardia 
by CAF (70%), congestive heart failure (70%), previous episodes of 
acute pulmonary edema (27%), stroke due to thromboembolism 
(13%), and peripheral embolism (7%); these patients required 
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Fig. 1 - Percentage distribution of valvular disease in patients with 
chronic atrial fibrillation.
Fig. 2 - Percentage distribution of symptoms and functional class in 
patients with chronic atrial fibrillation. 
class of patients, according to New York Heart Association (NYHA), 
was III/IV and the average size of the left atrium measured on 
echocardiography was approximately 60 mm.
Operations performed concurrently with the ablation 
included mitral valve replacement for bovine pericardial 
bioprosthesis of Braile Biomédica® (São José do Rio Preto, 
SP, Brazil) (69%), mitral valve repair (10%), reoperation with 
valve replacement (10%), and associated with tricuspid valve 
(11%) (Figure 3). In addition to ablation with US, in all patients, 
additional procedures to surgery included: exclusion of the 
right and left atria (90%), reduction in the size of the left atrium 
through resection and/or plication of the left atrial wall (25%), 
and thrombectomy (15%) (Figure 4).
Fig. 3 – Procedures performed concurrently with the CAF ablation.
Fig. 4 - Supplementary procedures to surgery of US ablation.
ABL=ablation; EXC RA-LA=exclusion of the right and left atria; RED
LA=reduction of the left atrium; Thromb=thrombectomy
     ABL       EXC RA-LA RED LA        THROMB
%
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Early results showed that 94% of patients undergoing US 
ablation reversed the rate of CAF, 86% being in sinus rhythm and 
8% in atrioventricular block, which was transient. Among 6% of 
the patients, there was no success, there were 4 reoperations, 
and left atrium with severe fibrosis caused by rheumatic fever 
and/or calcified (Figure 5). At the end of the procedure and at the 
end of CPB, 96% of patients maintained adequate cardiac output, 
even when CAF was not reversed. There was no reoperation for 
bleeding in the immediate postoperative period. In one patient, 
there was injury of the left atrium wall by US scalpel, corrected 
by suturing the left atrium. Median operation time was 142 
minutes with anoxic arrest of 45 minutes. The time to perform 
the ablation lines were 12.5 and 14 minutes for the right and left 
atria, respectively (Table 1).
Analyzing the results at hospital discharge, we observed 
maintenance of sinus rhythm in 86% of patients and recurrence 
of CAF in 8%. Hospital stay ranged from 5 to 12 days, with 
an average of 6.6 days. Four hospital deaths were recorded, 
two patients who underwent reoperation for calcified mitral 
restenosis had respiratory failure in the postoperative period, 
and two patients who had preoperative functional class IV and 
an episode of acute edema evolved with low output syndrome 
and unmanageable heart failure. These 4 patients had AF in 
the immediate postoperative period. One patient had sternal 
dehiscence.
After hospital discharge, patients were followed-up in 
outpatient clinics with conduction of CPB, 24-hour Holter, 
and echocardiogram, initially and at 15, 30, and 60 days 
postoperatively. Clinical follow-up of late postoperative 
period was performed at 12, 24, 36, 48 and 60 months after 
hospital discharge. Figure 6 shows the results of the relapse 
in the postoperative period. Follow-up time ranged from 12 
to 60 months. At follow-up after 60 months, 83.8% of patients 
maintained relapse-free sinus rhythm (Figure 7).
Reversal                Transient  AVB                Non-reversal
%
Fig. 5 - Results obtained in the immediate postoperative period for 











Fig. 6 - Results obtained postoperatively with respect to relapse of 
chronic atrial fibrillation in patients undergoing US ablation.
Table 1. Results on the median time (in minutes) of the surgical 
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Fig. 7 - Actuarial curve (Kaplan-Meier) for probability of remaining 
without recurrence up to 60 months of follow-up in 86 patients with 
chronic atrial fibrillation who underwent surgery with US.
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DISCUSSION
The results of this research show that the surgical treatment of 
chronic AF with US in patients with mitral valve disease is feasible. 
In most patients with CAF, rheumatic mitral valve disease, mitral 
regurgitation, palpitation related to tachycardia, and congestive 
heart failure are more frequent. The low rate of intraoperative 
and postoperative complications shows that surgical ablation of 
CAF with US concomitant with valve surgery is safe and effective. 
Maintenance of sinus rhythm rate after 60 months of follow-up 
for these patients shows the benefits of surgical ablation with US 
in the treatment of this arrhythmia.
Regarding functional class, all patients showed considerable 
improvement, staying mostly in class I or II, which indicates 
that maintenance of the rhythm with contraction of the atria 
positively influenced the results. In this study, although they are 
important in the evolution of patients and can influence the final 
results, variables such as size of the left atrium, left ventricular 
ejection fraction and functional class of CHF (NYHA) after surgery 
were not analyzed because what mattered was arrhythmia with 
maintenance or not of sinus rhythm.
Faced with poor results of clinical treatment and increased 
incidence of CAF, the pioneering study of Cox et al.[6] 
demonstrated the ability to surgically treat AF. Kong et al.[24] 
compared, through meta-analysis, the effectiveness of the Maze 
procedure with concomitant cardiac surgery versus drug therapy 
for treatment of patients with valvular AF. They concluded that 
surgical treatment is associated with reduced AF after 1 year, 
with no significant increase in the average length of hospital stay, 
postoperative complications or mortality from all causes.
Comparing the results of several studies in the literature on 
surgical treatment of CAF is difficult due to the large number of 
variables analyzed and the different classifications and treatment 
techniques. In a recent literature review, Brick & Braile[12] 
identified 72 studies on evolution and improvement of surgery 
of arrhythmias. Analyzing studies with immediate results, the 
percentage of return to sinus rhythm ranged from 73% to 96%, 
while those of long-term results (12 months on) ranged from 
62% to 97.7%. Both showed consequent clinical improvement of 
the patients who underwent ablation, regardless of the energy 
source used.
In this research, there was a careful attempt to standardize 
the sample, eliminating patients with other diseases developing 
CAF, such as congenital and coronary artery disease. Only 
patients with mitral and tricuspid valves were concurrently 
treated because performing ablation also in the right atria is 
important to eliminate possible sources of atrial flutter.
In this study, it was found that 75% of patients in a follow-
up of 60 months were in sinus rhythm after mitral valve surgery 
associated with ablation of the CAF using US as energy source. 
This result is consistent with the literature[12]. Meta-analysis of 
results of 62 studies on surgical ablation in patients with AF 
undergoing mitral valve surgery show a significantly higher rate 
of sinus rhythm in these patients, with no increase in mortality 
rate[16].
The ideal energy source would be fast, reliable, producing 
transmural lesions that would not damage the surrounding 
tissues, and capable of being used with CPB in minimally 
invasive endocardial and epicardial application. The first patients 
who underwent surgery by the author for correction of CAF 
with unipolar radiofrequency catheter were not included in 
this analysis. The development of bipolar ablation devices with 
irrigated catheter contributed to the technical improvement of 
the procedure with consequent shorter surgery and satisfactory 
operative results, showing a 96% rate of reversion to sinus 
rhythm[6]. It was followed by the emergence of the use of the US 
scalpel, which seemed more appropriate since it facilitated the 
procedure, with better results and less surgery time.
Benussi et al.[25] described radiofrequency application in 
patients with mitral valve disease. The procedure, similar to that 
performed by the author, also surrounded the right and left 
pulmonary veins, with exclusion of the left atrial appendage. 
After 36 months of development, 77% of the patients (n=132) 
were free of AF. In our series, after 60 months, sinus rhythm 
maintenance percentage, at 83.8%, was higher than that 
obtained by Benussi et al.[25].
For this author[6], the use of US with harmonic scalpel 
(UltraScision®) began after experiencing initial difficulty with 
a proper catheter to perform surgical radiofrequency ablation 
and using the US scalpel in surgery for treatment of refractory 
ventricular tachycardia in Chagas disease patients with left 
ventricular aneurysm. Currently, several devices have been 
developed using US for both endo- and epicardial application, 
facilitating the procedure and making surgery less invasive and 
safer.
The success rate of CAF reversal of this study is compared 
to that of other authors[15,20,26], using various energy sources and 
techniques, such as radiofrequency, cryoablation, and US, and 
performing the atrial ablation lines in the same way.
In this series, analyzing immediate and hospital outcomes, 
maintenance of sinus rhythm was observed in 94% and 86% of 
patients, respectively. Lins et al.[20], when comparing patients 
undergoing US ablation to those who did not, found that 80% 
of the patients treated with US were free of AF whereas, in the 
other group, that occurred to only 30% of the patients. The 
results observed in this study are similar to those obtained in the 
study presented herein, showing that US ablation can be applied 
in patients with surgical indication for mitral valve disease repair.
In this research, the right atrium approach (biatrial) was 
performed in all patients because it was considered important to 
treat and prevent atrial flutter, which is related to the vena cava 
and right atrium. When comparing results obtained in patients 
with AF associated with mitral valve disease who underwent left 
or biatrial atrial ablation, Kim et al.[27] found that biatrial ablation 
was more effective in restoring and maintaining sinus rhythm 
without increasing the risk of postoperative complications.
In this series, the operative results were also safe, with 
complications related to the ablation procedure (lesion in the left 
atrium) in only one patient and immediate results of reversion to 
sinus rhythm of 94% and 83.8% after 60 months. The reduction 
of recurrence rates to maintain sinus rhythm can be observed 
over time.
The operative times in this study were satisfactory compared 
with other techniques for the surgical treatment of CAF. Median 
time of operation was 142 minutes with anoxic arrest of 45 
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minutes. The time to perform the ablation lines was 12.5 minutes 
in the right atrium and 14 minutes in the left atrium.
The complications in the postoperative period, such as low 
cardiac output syndrome and respiratory failure, were not related 
to the non-reversal of arrhythmia; however, due to complications 
after surgery, those patients did not maintain sinus rhythm. In 
this study, mortality rate was 4%, unrelated to arrhythmia.
AF has been neglected for being considered benign. However, 
it is associated with many potentially lethal complications, with 
high morbidity and mortality rates. Some questions should be 
asked for the treatment of AF, namely: Is it reversible? What is 
the arrhythmia time? Are there related symptoms? Is there a 
structural disease base? In the case of mitral valve disease with 
surgical indication, what is the age and clinical condition of the 
patient? And, finally, what is the best treatment option and the 
impact on morbidity and mortality?
In addition to the endocardial application, US and other 
devices can be used in off-pump surgery, through epicardial 
application in patients with isolated fibrillation. The aim of the 
Consensus of the International Society for Minimally Invasive 
Cardiothoracic Surgery (ISMICS)[28] was to determine whether 
surgical ablation of AF during associated cardiac procedures 
improves postoperative clinical outcomes. The group involved in 
the study analyzed the best available evidence, with systematic 
data review, including randomized and nonrandomized 
controlled studies, always in descending order of importance. A 
systematic review with meta-analysis identified 10 randomized 
trials (650 patients) and 23 non-randomized (3997 patients) trials, 
mostly published in English and performed in the United States.
The authors of the consensus study defined the following 
recommendation: in patients with persistent and permanent 
AF, surgical ablation is recommended to increase the incidence 
of sinus rhythm in the short- and long-term (Class 1, Level A); 
reduce the risk of stroke and thromboembolic events (Class 
2a, level B); increase exercise tolerance and improve ventricular 
function (Class 2a, level A); and increase survival (Class 2a, level 
B)[28].
The use of the US technique for treatment of CAF with mitral 
valve disease is easy to perform, with a low complication rate 
and minimum surgical and CPB time. It can be reproduced by 
several cardiac surgery centers, requiring only the US scalpel, 
which exists in most hospitals that perform laparoscopic surgery. 
From the classic maze surgery (Cox Maze), changes in AF surgery 
have been occurring using alternative energy sources. The results 
of the surgical ablation of the CAF in patients with mitral valve 
disease depend on the energy source used, the lesion produced 
being transmural and applied in the two atria, and, with current 
technology, being minimally invasive.
CONCLUSION
Patients with rheumatic mitral valve disease often have 
mitral valve failure and mitral stenosis, palpitations related 
to tachycardia by CAF, and congestive heart failure. Surgical 
treatment of CAF with US concomitant with mitral valve surgery 
is feasible and satisfactory, with maintenance of sinus rhythm in 
most patients (83.8%) after 60 months of follow-up.
Surgical treatment of chronic atrial fibrillation 
with ultrasound.
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